Appraisal of New Drugs in Ireland

Appraisal of New Drugs in Ireland

Below is the appraisal pathways of expensive new drug therapies in Ireland.

 

Supply and Reimbursement of Drugs: From Clinical Trial to Patient Access


Assessment pathway for new drug therapies in Ireland

 

Source: Steering a course to avoid the ‘drug iceberg’ (Report 1.0)

For more information on how new therapies are approved in Ireland please contact our Research and Policy Officer, Daniel Costigan or please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it.